Congress Presentations
Stay informed about the latest scientific and medical research from Axsome.
AMCP Nexus 2024
Las Vegas, NV | October 14 - 17, 2024
AXS-05 | Major Depressive Disorder
Real-World Auvelity® (AXS-05) Patient Characteristics in Major Depressive Disorder
AXS-05 | Major Depressive Disorder
Dr. Andrew Muzyk, PharmD describes the “Real-World Auvelity® (AXS-05) Patient Characteristics in Major Depressive Disorder” Poster
AXS-05 | Major Depressive Disorder
Auvelity® (AXS-05) in Major Depressive Disorder: Pooled Data from Two Six-Week Controlled Trials (GEMINI and ASCEND)
AXS-05 | Alzheimer’s Disease Agitation
Clinical Profile of AXS-05 (Dextromethorphan-Bupropion) in Treating Alzheimer’s Disease Agitation: Results From The Phase 2/3 Development Program
AXS-05 | Alzheimer’s Disease Agitation
Dr. Jeffrey L. Cummings, MD, ScD describes the “Clinical Profile of AXS-05 (Dextromethorphan-Bupropion) in Treating Alzheimer’s Disease Agitation: Results From The Phase 2/3 Development Program” Poster
Migraine
Combined Efficacy and Safety of AXS-07 (MoSEICTM Meloxicam and Rizatriptan) in Two Phase 3 Clinical Trials
